Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference 2025 Transcript

Core Insights - Regeneron is actively participating in a well-attended conference, indicating strong interest and engagement from investors [2]. Group 1: Company Overview - Regeneron is represented by its team at the conference, highlighting its commitment to sharing its narrative and developments with investors [2]. - The company is led by Akash Tewari, a pharma and biotech analyst at Jefferies, who is facilitating the discussion and Q&A session [1]. Group 2: Forward-Looking Statements - The presentation includes forward-looking statements about Regeneron, which are subject to risks and uncertainties that may lead to actual results differing from projections [3]. - Regeneron does not commit to updating any forward-looking statements based on new information or future events, emphasizing the inherent uncertainties in the biotech industry [3].